BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//thebench.bio//Events//EN
CALSCALE:GREGORIAN
BEGIN:VEVENT
UID:event-84@thebench.bio
DTSTAMP:20261011T090430Z
DTSTART;VALUE=DATE:20270125
DTEND;VALUE=DATE:20270129
SUMMARY:Genetic Medicines to Treat Cardiovascular Disease (Keystone A2)
LOCATION:Keystone Resort\, Keystone\, CO\, United States
DESCRIPTION:Gene therapy\, RNA therapies\, stem cells and gene editing are 
 all on the table at this Keystone symposium on treating cardiovascular dis
 ease. Discussion covers new targets\, delivery\, efficacy and safety\, car
 diac tissue models\, long-term effects and regulatory questions\, plus pan
 els on moving from translation to commercialisation and working with ventu
 re capital. It runs alongside the genome engineering and nucleic acid deli
 very meetings in Keystone\, with a Career Roundtable for trainees.\n\nhttp
 s://www.keystonesymposia.org/conferences/conference-listing/meeting/a22027
URL:https://thebench.bio/events/genetic-medicines-to-treat-cardiovascular-d
 isease-keystone-a2-2027
END:VEVENT
END:VCALENDAR